Disclosure Of First-Time Adoption [Text Block]

Sopharma Trading AD - Filing #6022496

Concept As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
25 436 BGN
94 545 BGN
225,000 BGN
55 181 BGN
21 441 BGN
34 276 BGN
868,000 BGN
24 912 BGN
225,000 BGN
25 773 BGN
50 463 BGN
84 900 BGN
797,000 BGN
34 276 BGN
10 723 BGN
392,000 BGN
34 276 BGN
789,000 BGN
29 609 BGN
76 938 BGN
22 595 BGN
Comprehensive income
- BGN
- BGN
9 645 BGN
9 574 BGN
- BGN
- BGN
71,000 BGN
- BGN
- BGN
87,000 BGN
8,000 BGN
- BGN
7 962 BGN
8 041 BGN
Profit (loss)
- BGN
- BGN
9 080 BGN
9 080 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
8 050 BGN
8 050 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.